| Patent | Date |
|---|
Methods And Compositions For Treating Neurological Conditions
App 20200368177 - LIPTON; Stuart A. | 2020-11-26 |
Neuroprotective compositions and methods
Grant 8,466,311 - Lipton , et al. June 18, 2 | 2013-06-18 |
Neuroprotective Compositions and Methods
App 20120296112 - Lipton; Stuart A. ; et al. | 2012-11-22 |
Methods of differentiating and protecting cells by modulating the p38/MEF2 pathway
Grant 8,236,563 - Lipton , et al. August 7, 2 | 2012-08-07 |
Excitatory glycine receptors and methods
Grant 8,193,315 - Lipton , et al. June 5, 2 | 2012-06-05 |
Treatment Of Insulin Resistance/metabolic Syndrome To Alleviate The Risks Of Dementia
App 20110293556 - LIPTON; Stuart A. ; et al. | 2011-12-01 |
Methods Of Differentiating And Protecting Cells By Modulating The P38/mef2 Pathway
App 20110212070 - Lipton; Stuart A. ; et al. | 2011-09-01 |
Pathologically-activated Therapeutics
App 20110171291 - Lipton; Stuart A. | 2011-07-14 |
Media Conditioned By Stem Cells And Uses Therefor
App 20110091568 - Lipton; Stuart A. ; et al. | 2011-04-21 |
Methods of differentiating and protecting cells by modulating the P38/MEF2 pathway
Grant 7,919,317 - Lipton , et al. April 5, 2 | 2011-04-05 |
Excitatory Glycine Receptors And Methods
App 20110045098 - LIPTON; STUART A. ; et al. | 2011-02-24 |
Excitatory glycine receptors and methods
Grant 7,790,404 - Lipton , et al. September 7, 2 | 2010-09-07 |
Methods for Treating Neuropsychiatric Disorders with NMDA Receptor Antagonists
App 20100137448 - Lipton; Stuart A. ; et al. | 2010-06-03 |
Treatment of Demyelinating Conditions
App 20090234021 - Lipton; Stuart A. ; et al. | 2009-09-17 |
Neuroprotective Synergy Of Erythropoietin And Insulin-like Growth Factors
App 20090093409 - Digicaylioglu; Murat ; et al. | 2009-04-09 |
Treatment of Insulin Resistance/Metabolic Syndrome to Alleviate the Risks of Dementia
App 20090088367 - Lipton; Stuart A. ; et al. | 2009-04-02 |
Neuroprotective compositions and methods
App 20090042980 - Lipton; Stuart A. ; et al. | 2009-02-12 |
Neuroprotective synergy of erythropoietin and insulin-like growth factors
Grant 7,439,063 - Digicaylioglu , et al. October 21, 2 | 2008-10-21 |
Aminoadamantane Derivatives As Therapeutic Agents
App 20080183003 - Wang; Yuqiang ; et al. | 2008-07-31 |
Aminoadamantane derivatives as therapeutic agents
Grant 7,326,730 - Wang , et al. February 5, 2 | 2008-02-05 |
Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor
App 20070292400 - Lipton; Stuart A. ; et al. | 2007-12-20 |
Compounds that inhibit caspase activity for treating glaucoma
App 20070218121 - Lipton; Stuart A. | 2007-09-20 |
Protein 68075 and its use for regenerating nerve cell processes
Grant 7,091,329 - Lipton August 15, 2 | 2006-08-15 |
Aminoadamantane derivatives as therapeutic agents
App 20060106222 - Wang; Yuqiang ; et al. | 2006-05-18 |
Neuroprotective synergy of erythropoietin and insulin-like growth factors
App 20050197284 - Digicaylioglu, Murat ; et al. | 2005-09-08 |
Method of targeting a therapeutic agent
App 20050124701 - Went, Gregory T. ; et al. | 2005-06-09 |
Treatment of demyelinating conditions
App 20050065219 - Lipton, Stuart A. ; et al. | 2005-03-24 |
Pharmaceutical compositions for treating painful neuropathy and methods of treating same
App 20050004022 - Digicaylioglu, Murat ; et al. | 2005-01-06 |
Compounds that inhibit caspase activity for treating glaucoma
App 20040265369 - Lipton, Stuart A. | 2004-12-30 |
Methods for treating neuropsychiatric disorders with nmda receptor antagonists
App 20040122090 - Lipton, Stuart A. | 2004-06-24 |
Neuroprotective synergy of erythropoietin and insulin-like growth factor
App 20040092444 - Digicaylioglu, Murat ; et al. | 2004-05-13 |
Excitatory glycine receptors and methods
App 20040033500 - Lipton, Stuart A. ; et al. | 2004-02-19 |
Aminoadamantane derivatives as therapeutic agents
App 20040029929 - Wang, Yuqiang ; et al. | 2004-02-12 |
Aminoadamantane derivatives as therapeutic agents
Grant 6,620,845 - Wang , et al. September 16, 2 | 2003-09-16 |
NMDA oxidizing agents for protecting neurons from injury
App 20030100482 - Lipton, Stuart A. | 2003-05-29 |
Excitatory glycine receptors and methods
App 20030092004 - Lipton, Stuart A. ; et al. | 2003-05-15 |
Method of reducing neuronal injury or apoptosis
App 20030078274 - Lipton, Stuart A. | 2003-04-24 |
Aminoadamantane derivatives as therapeutic agents
App 20030008889 - Wang, Yuqiang ; et al. | 2003-01-09 |
Method of treating cytotoxic damage
Grant 6,503,947 - Lipton , et al. January 7, 2 | 2003-01-07 |
Glaucoma treatment
Grant 6,482,854 - Lipton , et al. November 19, 2 | 2002-11-19 |
Compounds that inhibit caspase activity for treating glaucoma
App 20020106404 - Lipton, Stuart A. | 2002-08-08 |
Methods of differentiating and protecting cells by modulating the P38/MEF2 pathway
App 20020090603 - Lipton, Stuart A. ; et al. | 2002-07-11 |
Glaucoma treatment
Grant 5,922,773 - Lipton , et al. July 13, 1 | 1999-07-13 |
Method of preventing NMDA receptor complex-mediated Neuronal damage
Grant 5,747,545 - Lipton May 5, 1 | 1998-05-05 |
Method of preventing NMDA receptor-mediated neuronal damage
Grant 5,614,560 - Lipton March 25, 1 | 1997-03-25 |
Regimen method of mediating neuronal damage using nitroglycerine
Grant 5,455,279 - Lipton October 3, 1 | 1995-10-03 |
Method of preventing NMDA receptor-mediated neuronal damage
Grant 5,334,618 - Lipton August 2, 1 | 1994-08-02 |
Method of preventing NMDA receptor complex-mediated neuronal damage
Grant 5,234,956 - Lipton August 10, 1 | 1993-08-10 |
| 